Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0002043395-26-000012

Chief Medical Officer sold 12,000 shares at $12.18 ($146,160)

  • Chief Medical Officer acquired 168 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sayad Pierre Sargis · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-31 Grant or award : show line 1 in the form +168 21,519 D
2026-08-31 Sale : show line 2 in the form −12,000 $12.18 $146,160 9,519 D
Open-market sales · 12,000 sh · avg $12.18 · $146,160
Loading xslF345X06/form4-09012026_120920.xml…